The future of multiple sclerosis treatments

Coclitu, Catalina and Constantinescu, Cris S. and Tanasescu, Radu (2016) The future of multiple sclerosis treatments. Expert Review of Neurotherapeutics, 16 (12). ISSN 1744-8360

[img] PDF - Repository staff only until 21 October 2017. - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (462kB)

Abstract

Introduction. There are not many conditions in which the last few decades have brought such a major change in the landscape of treatments as is the case of multiple sclerosis (MS). A number of disease modifying treatments (DMTs) are presently available for the treatment of the inflammatory phase of this disabling disease; however, the need for treating neurodegeneration and halting the progression of disability is still unmet.

Areas covered: In this paper we review the available information on existing and emerging DMTs and we discuss their place within the context of different treatment strategies in MS.

Expert Commentary: The future of MS treatments should include the development of new treatment strategies tackling disease progression, together with a better understanding of the side-effects and the best sequential strategy of implementation of available and emerging drugs.

Item Type: Article
Keywords: Multiple sclerosis, Immunomodulation, Monoclonal antibodies, Remyelination, Repurposing
Schools/Departments: University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine
Identification Number: https://doi.org/10.1080/14737175.2016.1243056
Depositing User: Eprints, Support
Date Deposited: 19 Oct 2016 09:43
Last Modified: 24 Feb 2017 20:30
URI: http://eprints.nottingham.ac.uk/id/eprint/37718

Actions (Archive Staff Only)

Edit View Edit View